Recent Articles from Investor Brand Network

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

BluSky AI (OTC: BSAI) is positioning at the forefront of a major shift in artificial intelligence infrastructure, where flexibility and predictable access to compute resources are becoming mission critical. “With AI workloads increasing at unprecedented rates, organizations are changing their outlook on traditional hyperscale cloud providers and finding alternatives that reduce vendor lock-in, provide the compute that is quickly becoming unavailable, while enhancing cost visibility and performance reliability. The company’s approach, anchored in the design of modular and quickly deployable data centers, offers a compelling solution for this evolving landscape,” a recent article reads.

Earth Science Tech (OTC: ETST), a strategic holding company, was featured in a recent article that discussed its strives to build value by acquiring and actively managing businesses. The publication reads, “Earth Science Tech takes an approach that prioritizes capital discipline, execution, and long-term value creation across the platforms it operates, while focusing on scaling businesses that can grow sustainably and increase shareholder value. The wholly owned and majority-owned subsidies that the company operates include: Mister Meds LLC: A compounding pharmacy that delivers personalized wellness plans and dedicated support to patients across the USA… RxCompoundStore.com LLC: Another compounding pharmacy that’s authorized to fulfill prescriptions across over 20 states and Puerto Rico… Peaks Curative LLC: A company and telemedicine referral platform that provides doctor-verified telehealth treatments… Las Villas Health Care Inc.: A healthcare provider that serves the Spanish-speaking community and offers personalized wellness programs… DOConsultations LLC: A telehealth platform that offers personalized health wellness programs and supports direct delivery through the company’s partner pharmacies… Earth Science Foundation Inc.: A nonprofit organization that acts as the charitable arm of the company and provides qualified individuals with financial assistance related to prescription costs.”

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

As supply deficits continue to influence platinum markets, the precious metal has registered a 30% climb in its price so far this year. This is according to a report on commodity prices published in April by the World Bank.

Earth Science Tech (OTC: ETST), a strategic holding company, was featured in a recent article that discussed its strives to build value by acquiring and actively managing businesses. The publication reads, “Earth Science Tech takes an approach that prioritizes capital discipline, execution, and long-term value creation across the platforms it operates, while focusing on scaling businesses that can grow sustainably and increase shareholder value. The wholly owned and majority-owned subsidies that the company operates include: Mister Meds LLC: A compounding pharmacy that delivers personalized wellness plans and dedicated support to patients across the USA… RxCompoundStore.com LLC: Another compounding pharmacy that’s authorized to fulfill prescriptions across over 20 states and Puerto Rico… Peaks Curative LLC: A company and telemedicine referral platform that provides doctor-verified telehealth treatments… Las Villas Health Care Inc.: A healthcare provider that serves the Spanish-speaking community and offers personalized wellness programs… DOConsultations LLC: A telehealth platform that offers personalized health wellness programs and supports direct delivery through the company’s partner pharmacies… Earth Science Foundation Inc.: A nonprofit organization that acts as the charitable arm of the company and provides qualified individuals with financial assistance related to prescription costs.”

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on cancer therapeutics, announced it has been named an Emerald honoree at the 2026 Pinnacle Awards for Healthcare, recognized for its innovative approach to addressing cancer drug resistance. The company’s strategy centers on resistance-modulating treatments, including its lead candidate ENV-105 (carotuximab), designed to inhibit tumor resistance pathways and enhance the effectiveness of existing therapies, as Kairos advances combination approaches aimed at improving durability of response across multiple cancer indications.

Safe Pro Group (NASDAQ: SPAI), an AI-enabled defense and security solutions provider, announced it successfully completed a U.S. Army live fire exercise where its patented AI technology processed drone imagery at the edge to detect live scattered mines and deliver actionable intelligence to commanders. The exercise builds on a prior government contract and supports the rollout of the company’s NODE-X edge computing system, which leverages its SPOTD AI platform trained on millions of real-world images to identify explosive threats, generate 3D terrain models and enhance battlefield situational awareness, as Safe Pro continues engagement with Army stakeholders and prepares for additional exercises in the second quarter of 2026.

Recent geopolitical conflict and supply disruptions have underscored how vulnerable global energy systems remain, with oil markets particularly exposed to shocks that can ripple through economies and industries almost instantly. The current situation has renewed the urgency of finding new approaches to domestic, feedstock-driven energy production are gaining urgency. Frontieras North America is advancing one such model through its proprietary technology that transforms coal into fuels, hydrogen and industrial products, positioning the resource as a strategic alternative in a constrained energy environment.

Knightscope (NASDAQ: KSCP), a developer of autonomous security technologies, announced a collaboration with Carnegie Mellon University’s School of Computer Science to support educational projects focused on robotics for national security and public safety, while helping strengthen the U.S. robotics workforce. Under the agreement, Knightscope will fund five course projects over five years and provide access to its National Security Robotics Lab, as graduate students from Carnegie Mellon’s Robotics Institute are already working with the company on advanced AI features for its upcoming K7 Autonomous Security Robot, supporting efforts to accelerate innovation and real-world deployment of next-generation autonomous systems.

Massimo Group (NASDAQ: MAMO) announced it has entered into a strategic cooperation agreement with Shenzhen AIBO Robotics Co. Ltd. to support expansion into intelligent commercial automation, robotic service systems and AI-enabled equipment upgrades, initially targeting the United States and China. The company plans to leverage its manufacturing, deployment and commercialization capabilities to scale robotics solutions across commercial and industrial environments while evaluating AI-driven enhancements to its existing vehicle platforms, including semi-autonomous navigation, remote monitoring and smart mobility applications, as it positions to capture opportunities in the growing global service and security robotics markets.

Polyrizon (NASDAQ: PLRZ), a pre-clinical-stage biotechnology company developing intranasal protective solutions, announced the closing of its previously announced registered direct offering and concurrent private placement with a single institutional investor, generating approximately $3.5 million in gross proceeds. The transactions included the sale of 388,888 units or pre-funded units at a combined price of $9.00 per unit, consisting of ordinary shares or pre-funded warrants and common warrants, with additional pre-funded and common warrants issued in the private placement, as the company plans to use proceeds for working capital and general corporate purposes, while Aegis Capital Corp. acted as exclusive placement agent.

Amazon.com (NASDAQ: AMZN) is making a strategic move into satellite connectivity with its approximately $11.6 billion acquisition of Globalstar, positioning the deal as a direct challenge to SpaceX’s Starlink while securing critical direct-to-device capabilities and a key partnership with Apple, according to a report from Channelchek. The acquisition provides Amazon with valuable spectrum licenses and satellite infrastructure that would be difficult to replicate, enabling plans for a direct-to-device network by 2028, while also establishing Amazon as a potential backend connectivity provider for Apple’s ecosystem, as the transaction highlights intensifying competition in the low-Earth orbit satellite market and a broader push to control next-generation global connectivity infrastructure.

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising.

A new survey by Gallup shows that Gen Z is becoming more negative toward artificial intelligence, even as the technology continues to grow in schools and workplaces. The findings suggest that while young people still use AI tools, many are starting to question how helpful and safe these tools really are in the long term.

Canadian scientists have made an unexpected finding about glioblastoma, one of the deadliest and hardest-to-treat forms of brain cancer. Cells previously regarded as passive support structures in healthy brain tissue have been found to actively fuel tumor growth through signaling that boosts cancer cell function.

Spot gold started the week with a pullback, losing 0.2% to trade at $4,740 per ounce. On Tuesday, the metal recovered slightly and started the day at $4,758. These losses came as the talks between the United States and Iran fell through over the weekend and the dollar regained its momentum.

Tonix Pharmaceuticals (NASDAQ: TNXP), a commercial-stage biotechnology company, announced the publication of a peer-reviewed study detailing the steady-state pharmacokinetic properties of TNX-102 SL, the sublingual formulation of cyclobenzaprine HCl marketed as TONMYA(R), in Clinical Pharmacology in Drug Development . The study, conducted in 60 healthy volunteers, demonstrated that the sublingual formulation achieves faster absorption, earlier peak plasma concentration and higher dose-normalized bioavailability compared to oral extended-release cyclobenzaprine, supporting its use for long-term bedtime dosing to target nonrestorative sleep in fibromyalgia, reduce pain and improve related symptoms.

Proton therapy is a specialized cancer treatment that uses precision-guided radiation beams to target and destroy tumors while limiting harm to surrounding healthy tissue. While it has been around for decades, it’s been largely inaccessible for many cancer patients due to both the huge footprint of traditional proton therapy equipment and the high costs. However, some programs have recently turned their heads to proton therapy and are attempting to make it more accessible for those who can benefit from it.

NRx Pharmaceuticals (NASDAQ: NRXP), a biopharmaceutical company focused on neuroplastic therapies for depression and PTSD, announced the formation of NRx Defense Systems Inc., a Florida-based research and development subsidiary dedicated to advancing combined neuroplastic treatments using D-cycloserine and transcranial magnetic stimulation supported by robotic-enabled neuronavigation. The subsidiary will be led by Dr. Dennis McBride, with support from Chief Medical Innovation Officer Dr. Joshua Brown, and aims to pursue non-dilutive government and institutional funding while developing deployable solutions for military and first responder use, including a prototype in partnership with Zeta Surgical Inc. expected to be unveiled at the Clinical TMS Society annual meeting in June 2026.

NRx Pharmaceuticals (NASDAQ: NRXP), a biopharmaceutical company focused on neuroplastic therapies for depression and PTSD, announced the formation of NRx Defense Systems Inc., a Florida-based research and development subsidiary dedicated to advancing combined neuroplastic treatments using D-cycloserine and transcranial magnetic stimulation supported by robotic-enabled neuronavigation. The subsidiary will be led by Dr. Dennis McBride, with support from Chief Medical Innovation Officer Dr. Joshua Brown, and aims to pursue non-dilutive government and institutional funding while developing deployable solutions for military and first responder use, including a prototype in partnership with Zeta Surgical Inc. expected to be unveiled at the Clinical TMS Society annual meeting in June 2026.

American Fusion (OTC: AMFN), a developer of next-generation fusion energy technologies, announced it has entered into an advisory agreement with Samuel Reid, who will serve as Government Strategy and Procurement Advisor to support efforts to secure non-dilutive government funding, institutional contracts and alignment with U.S. and international fusion initiatives. Reid brings experience in government contracting, defense procurement and international agency engagement, including work with NATO-affiliated procurement bodies and the Canadian Department of National Defence, and currently serves as founder and CEO of Geometric Energy Corporation, as the company positions government and defense channels as a near-term pathway for funding, early-stage revenue and long-term institutional adoption.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.

HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care innovation, announced it is commencing an underwritten public offering of shares of its common stock or common stock equivalents, with all securities to be offered by the company and the final size and terms subject to market conditions. The company said it intends to use net proceeds from the offering to advance commercialization of its FDA-cleared 12-lead synthesized ECG system, further development of its extended-wear patch and heart attack detection initiatives, enhance its AI capabilities and support working capital and general corporate purposes, with Titan Partners, a division of American Capital Partners, acting as sole bookrunner.

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ), a smart retail technology company, announced a series of business updates highlighting record smart cart purchase orders exceeding $175 million over the life of contracted deployments, excluding retail media revenue, representing more than 17,000 smart carts for leading retailers in Israel and Central America. The company said it delivered 500 smart carts in the first quarter of 2026, bringing total deliveries to 2,500 units, and expects all current retail partners to have deployments in place by no later than the third quarter of 2026, supported by a dedicated large-scale assembly plant expected to come fully online by then. A2Z also reported more than 1 million transactions processed through its platform, strong shopper adoption and retail performance gains, initial retail media revenue in the first quarter of 2026, new operational hubs in Bulgaria and Panama, plans to establish a European subsidiary and an upcoming shift to U.S. GAAP financial reporting beginning in the first quarter of 2026.

Beeline Holdings (NASDAQ: BLNE) announced a strategic partnership with Structured Real Estate Group to integrate its Embedded Mortgage and Title solutions into SRG’s AI-driven real estate platform, enabling homebuyers to access personalized financing, evaluate total ownership costs and initiate the mortgage process within a single digital environment. The collaboration will support the development of approximately 2,000 smart homes in the Dallas-Fort Worth area over the next 36 months, combining advanced home technology, energy-efficient systems and integrated infrastructure with Beeline’s AI-powered assistant “Bob” to streamline the homebuying journey, reduce friction and deliver a more transparent, efficient path to homeownership while advancing Beeline’s broader strategy to scale its embedded platform and expand its partner network.

Independent research coverage can play a meaningful role in shaping how emerging biotechnology companies are evaluated, particularly when it brings together clinical progress, financial positioning and forward-looking milestones into a cohesive outlook. A recent analysis from Zacks Small-Cap Research provides that perspective for Soligenix (NASDAQ: SNGX), offering a detailed review of the company’s pipeline, upcoming catalysts and valuation potential while reinforcing the credibility of its development strategy.

A newly published study points to a possible step forward in efforts to create a cannabis breathalyzer, offering early evidence that a compact and affordable device could detect recent cannabis use without requiring laboratory testing.

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

Soligenix (NASDAQ: SNGX) was featured in a recent article that discussed its positioning in a landscape where modern biopharmaceutical innovation often revolves around a powerful idea: One scientific mechanism can unlock treatments for multiple diseases. “Soligenix exemplifies this strategy through its use of synthetic hypericin across two distinct dermatologic indications, illustrating how platform science can streamline development and expand clinical impact,” the publication reads. “Platform-based drug development has gained traction across the biotechnology industry because of its efficiency and risk management advantages. In drug development, platform technology is a foundational technology or system that serves as a base for the development of multiple products, solutions or applications, particularly in the life sciences, pharmaceutical and biotech industries. By leveraging a shared mechanism of action, manufacturing process or delivery system, companies can reduce redundancy in preclinical work, regulatory documentation and safety validation.”

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

Next-generation system advances real-time drone threat detection and battlefield intelligence capabilities

SKYX Platforms (NASDAQ: SKYX) announced a strategic collaboration with European real estate and hotel developer Jean-François Ott and Group OTT to implement SKYX’s smart home and building technologies as a standard across new and existing properties in Europe, with the potential to reduce renovation and construction time and costs by up to 90% while enhancing safety and efficiency.

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

Fresh economic data is intensifying concerns that the global economy, particularly the U.S., may be drifting into a stagflationary environment . March inflation surged more than expected, while growth indicators continue to soften, creating a difficult backdrop for policymakers.

BMW’s hydrogen vehicle program has moved from extended research into active production planning, and the iX5 Hydrogen is the clearest expression of that shift. Industry reaction has been genuinely positive, though tempered by a recognition that hydrogen’s commercial future depends heavily on factors beyond any single vehicle’s specifications.

Glioblastoma is a deadly type of brain cancer which progresses rapidly and kills victims within months. For nearly two decades, no significant progress has been made in developing an effective treatment against this malignancy. Now, a new preclinical study using animal models has unveiled a potential breakthrough that could eliminate these tumors.

OpenAI has secured a record-setting $122 billion in new funding, pushing its valuation to roughly $852 billion after the deal. The deal stands as the largest private capital raise ever completed, highlighting a sharp shift in how global investors view the long-term value of AI.

Major technology companies have set ambitious clean energy targets, with leading names committing to carbon neutrality or 24/7 renewable power by the end of the decade. Those goals face a structural obstacle: AI facilities need uninterrupted power, while wind and solar output is inherently variable across hours and seasons.

Debate has intensified within the Bitcoin community over reports that Iran may consider accepting the crypto as payment for oil tanker transit through the Strait of Hormuz, a route that carries roughly one-fifth of the world’s oil supply.

AI hyperscalers like Google and Microsoft are seeking to secure DRAM supplies from leading manufacturers Samsung Electronics and SK Hynix under long term arrangements . This comes as the supply of memory contracts and prices of NAND flash and DRAM increase sharply.

Online dating has become a normal way for people to meet and build relationships. Many women already know how to spot obvious red flags, like rude messages or suspicious profiles. However, some warning signs are not so easy to notice. These subtle red flags can be more dangerous because they seem harmless at first. Understanding them can help women protect their time, emotions, and safety.

This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising.

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.

Datavault AI (NASDAQ: DVLT) has entered a consulting partnership with AgSensor Solutions to identify, value and tokenize high-value agricultural data assets, targeting sectors such as soil sensing, sustainability data and agricultural IoT. The agreement leverages AgSensor’s industry expertise alongside Datavault AI’s Information Data Exchange (R), DataScore (R) and DataValue (R) platforms to create tokenized assets tied to the global agricultural economy, offering producers and technology providers a compliant pathway to monetize data while expanding the company’s real-world asset tokenization strategy.

Focus Universal (NASDAQ: FCUV) has entered into definitive agreements with institutional investors for a private placement expected to generate approximately $4.0 million in gross proceeds through the sale of common stock, pre-funded warrants and accompanying Series A and Series B warrants priced at $3.58 per unit. The offering, priced at-the-market under Nasdaq rules and expected to close around April 7, 2026, will support general corporate purposes and working capital, with Aegis Capital Corp. serving as exclusive placement agent.

Lantern Pharma (NASDAQ: LTRN) announced the commercial launch of withZeta.ai, its multi-agentic AI co-scientist platform for rare cancer drug discovery, with subscriptions now available across academic and commercial tiers, creating a new non-dilutive revenue stream for the company. The platform, built from Lantern’s RADR (R) oncology-focused AI technologies, will be showcased at a private investor event at Nasdaq MarketSite in New York on April 16, 2026, and demonstrated publicly at the AACR Annual Meeting in San Diego from April 17–22, highlighting its capabilities in accelerating molecular design, clinical development and biomedical research.

NextPlat (NASDAQ: NXPL, NXPLW) reported that its Global Telesat Communications Ltd subsidiary has received approximately $400,000 in new orders for satellite-enabled IoT hardware, supporting an existing military end-user in Eastern Europe and a new customer in Asia, as demand from providers including Globalstar and Iridium continues to grow. The orders follow a recent $820,000 contract tied to a NATO military customer, bringing total IoT-related orders secured in the first quarter of 2026 to more than $1.2 million, reflecting expanding momentum in government, defense and enterprise connectivity markets alongside anticipated growth from the company’s expanding healthcare operations, according to CEO David Phipps.

Forward Industries (NASDAQ: FWDI) has appointed Mark Brazier as chief financial officer, effective April 13, 2026, succeeding Kathleen Weisberg, who will remain with the company as director of financial reporting. Brazier brings extensive experience in digital assets and institutional finance, most recently serving as CFO and head of regulatory at XBTO Global, and will oversee financial operations, capital structure, reporting and capital markets activities as the company continues to expand its position as a publicly traded Solana treasury company, with leadership citing his expertise at the intersection of traditional finance and crypto as key to supporting future growth.

This article has been disseminated on behalf of Search Minerals Inc. and may include paid advertising.

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising.

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.

Low-dose THC drinks may be gaining shelf space in bars and retail chains, but they are not resonating with marijuana shoppers in California, according to industry representatives .

Beyond Meat (NASDAQ: BYND) has fallen from a peak valuation of more than $14 billion to penny stock territory, driven by a combination of declining sales, mounting losses, intensifying competition and eroding consumer demand, according to a MarketWatch report by Bill Peters and Tomi Kilgore . Once buoyed by IPO enthusiasm and expectations of mass adoption, the company now faces a shrinking addressable market, widening price gaps with traditional meat and continued cash burn, with revenue falling 20% and operational losses more than tripling in recent results.

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

Safe Pro Group (NASDAQ: SPAI), a developer of AI-enabled defense, security, and situational awareness solutions, recently announced the appointment of Colonel (Ret.) Jarret Mathews as Chief Operating Officer (“COO”) ( https://ibn.fm/7QDQk ).

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

Xeriant (OTCQB: XERI), a company focused on developing and commercializing advanced technologies, announced the completion of a critical phase of internal testing for its NEXBOARD(TM) composite building panel, demonstrating strong fire-resistant performance ahead of third-party certification. The company is preparing for formal NFPA 286 and ASTM E84 testing, following internal trials showing no combustion or smoke under extreme heat, while refining manufacturing processes to support scalable production as it moves toward commercialization and broader adoption in residential and commercial construction.

Datavault AI (NASDAQ: DVLT), a provider of data monetization, credentialing, digital engagement and real-world asset tokenization technologies, announced plans to list its proprietary meme coin portfolio and RWA token suite on the Biconomy exchange, targeting expanded liquidity and distribution across Southeast Asian and global markets. The listings will include Dream Bowl and Josh Gibson-themed digital assets alongside RWA stablecoins, building on the company’s existing TRITON token already trading on Biconomy, as Datavault advances its tokenization pipeline and broader Information Data Exchange strategy while leveraging the platform’s global user base and trading volume to drive adoption visibility for emerging football talent through a broad sports and entertainment audience.

Greenland Energy (NASDAQ: GLND) announced its placement in an editorial published by NetworkNewsWire, highlighting how rising geopolitical tensions and disruptions to critical shipping routes such as the Strait of Hormuz are underscoring ongoing vulnerabilities in global energy security. The editorial emphasizes growing investor focus on companies advancing resource development in politically stable regions, positioning Greenland Energy as a key player through its exploration efforts in the Jameson Land Basin as part of broader efforts to strengthen Western energy independence.

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company advancing cancer treatments, announced preliminary results from a clinical trial evaluating its proprietary compound LB-100 in combination with dostarlimab at the 2026 Society of Gynecologic Oncology conference in San Juan, Puerto Rico. Interim data from 20 evaluable patients showed a 40% disease control rate and encouraging survival trends with an acceptable safety profile, supporting continued enrollment of an expanded cohort as the company investigates the combination’s potential to enhance immunotherapy response in ovarian clear cell carcinoma.

Stanford University scientists developed a molecular urine analysis that can distinguish bladder cancer patients who need immunotherapy from those already cured by surgical removal, transforming treatment planning for roughly 60,000 Americans diagnosed yearly with early-stage disease.

The rise of artificial intelligence has sparked fear and uncertainty about the future of work, especially for people just starting their careers. Many believed that entry-level jobs would disappear as machines took over basic tasks. However, new insights from HR leaders tell a different story. Instead of replacing these roles, AI is transforming them in ways that are both exciting and challenging.

American Fusion (OTC: AMFN) a developer of next-generation fusion energy technologies, reported its participation in the 2026 ARPA-E Energy Innovation Summit, where the company advanced its commercialization strategy, strengthened relationships with government agencies, research institutions and industry participants, and refined its positioning within the evolving fusion landscape. The company highlighted progress on its Texatron(TM) roadmap, identified data centers as a key initial customer segment for high-density power solutions, evaluated supply chain partnerships for critical inputs such as helium-3 and deuterium, and explored potential capital markets expansion, including a Frankfurt listing, as it moves toward scalable deployment of its modular fusion technologies.

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising.

This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising.

Oragenics (NYSE American: OGEN), a clinical-stage biotechnology company focused on brain-targeted therapeutics, announced that the first patient has been dosed in its Phase IIa clinical trial evaluating ONP-002 for concussion and mild traumatic brain injury at Mackay Hospital in Australia, shortly after site activation on March 31, 2026. The milestone follows regulatory approval and highlights progress in advancing a first-in-class intranasal neurosteroid designed to address underlying brain injury mechanisms, as the company expands trial sites and targets a large unmet need in a condition with no FDA-approved pharmacological treatments.

Safe Pro Group (NASDAQ: SPAI), a developer of AI-enabled defense, security and situational awareness solutions, announced the commercial rollout of its NODE-X, a next-generation, miniaturized AI-powered edge compute processor designed to analyze drone footage for real-time threat detection in military missions, following a recent government contract award. The backpack-deployable system leverages the company’s patented SPOTD technology trained on millions of real-world images to detect threats such as landmines, UXO and drones, while generating 3D mapping and route guidance without connectivity, and is scheduled for additional U.S. Army exercises through the second quarter of 2026 as Safe Pro scales production to meet growing defense demand.

NRx Pharmaceuticals (NASDAQ: NRXP), a biopharmaceutical company focused on neuroplastic therapies for depression, PTSD and related conditions, announced the appointment of Glenn Tyson as its first Chief Commercial Officer as the company prepares for anticipated approval of its Abbreviated New Drug Application for a preservative-free ketamine product. Tyson brings more than 25 years of commercialization and sales experience, including senior leadership roles at GSK and Indivior, where he led the successful launch of SUBLOCADE(R), and will oversee the buildout of market access, distribution, sales and marketing capabilities to support upcoming product launches and the company’s broader psychiatry pipeline, including NRX-100 and NRX-101.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

The global train collision avoidance market is undergoing a dramatic transformation, driven by the convergence of advanced camera systems and artificial intelligence. Rail Vision Ltd. (NASDAQ: RVSN, FSE: C80) is positioning itself squarely at the center of that shift, developing proprietary AI-integrated sensing platforms designed to detect hazards in real time and ultimately enable fully autonomous train operations.

ParaZero Technologies (NASDAQ: PRZO), an aerospace defense company specializing in autonomous solutions for manned and unmanned aerial systems, announced it has received a second purchase order from a defense entity for its DefendAir Counter-Unmanned Aerial Systems solution following prior evaluation and training. The order includes Personal Net Launchers, net pods and a comprehensive training package designed to support rapid deployment and operational readiness, reinforcing ParaZero’s growing presence with defense partners and highlighting demand for its non-kinetic, multi-layered drone interception technology, which has demonstrated 100% success in field trials and supports flexible configurations for urban, battlefield and infrastructure protection.

On a cold Friday afternoon near the New York–Pennsylvania border, cars begin to line up outside Organic Blooms, a recreational cannabis shop that has quickly become a regional draw. Vehicles with New York plates share space with those from Pennsylvania, a sign of a growing cross-border market fueled by differing state laws.